Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation

Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells.

Targeted oncology·2015

Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity.

British journal of cancer·2009

Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model.

Gut·2008

In vitro efficacy of recombinant diphtheria toxin-murine interleukin-4 immunoconjugate on mouse glioblastoma and neuroblastoma cell lines and the additive effect of radiation.

Neurosurgical focus·2006

Preclinical studies targeting normal and leukemic hematopoietic cells with Yttrium-90-labeled anti-CD45 antibody in vitro and in vivo in nude mice.

Cancer biotherapy & radiopharmaceuticals·2003

Chimeric fusion proteins--diphtheria toxin-based.

Current opinion in investigational drugs (London, England : 2000)·2001

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026

Reversing Dysfunction of CCR9+ Regulatory T Cells by Targeting the IL-21/IL-17 Axis Improves Type 1 Diabetes.

Diabetes, metabolic syndrome and obesity : targets and therapy·2026

The Patient With Multiple Alloantibodies: A Systematic Strategy for Antibody Identification and Transfusion Management.

Case reports in immunology·2026

Efficacy and safety of bispecific antibodies versus other antitumor therapies in solid tumors: a systematic review and meta-analysis.

Frontiers in immunology·2026

Related Experiment Videos

Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation

Related Concept Videos

Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells.

Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity.

Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model.

In vitro efficacy of recombinant diphtheria toxin-murine interleukin-4 immunoconjugate on mouse glioblastoma and neuroblastoma cell lines and the additive effect of radiation.

Preclinical studies targeting normal and leukemic hematopoietic cells with Yttrium-90-labeled anti-CD45 antibody in vitro and in vivo in nude mice.

Chimeric fusion proteins--diphtheria toxin-based.

Clinical Trials and Translational Advances in Metabolic Targeting.

Tools and Technologies for Studying Cancer Metabolism.

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Biomarkers of Cancer Metabolism and Therapeutic Response.

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Metabolic Reprogramming in Cancer Stem Cells.

Reversing Dysfunction of CCR9+ Regulatory T Cells by Targeting the IL-21/IL-17 Axis Improves Type 1 Diabetes.

The Patient With Multiple Alloantibodies: A Systematic Strategy for Antibody Identification and Transfusion Management.

Efficacy and safety of bispecific antibodies versus other antitumor therapies in solid tumors: a systematic review and meta-analysis.

Related Experiment Videos

Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation

Related Concept Videos

Related Articles